The author reflects on the issue concerning the prognostic score systems for hepatocellular carcinoma. The author asserts that the medicine lack prognostic tools that able to adequately express the medical complexity of hepatocellular carcinoma. The author suggests that the global gene expression profiling may be the most appropriate technology to explore heterogenous origin of hepatocellular carcinoma.